Jeena Sikho Lifecare Limited has officially notified stock exchanges that it does not qualify as a Large Corporate under SEBI's regulatory framework for the financial year 2026. The company submitted this disclosure to both the National Stock Exchange of India Limited and BSE Limited on April 16, 2026, ensuring compliance with regulatory requirements.

Regulatory Compliance Framework

The notification was made pursuant to several SEBI circulars, including SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, and circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023. These circulars pertain to fund raising by issuance of debt securities by large entities and establish specific criteria for Large Corporate classification.

Financial Position and Classification Details

The company provided detailed financial information to support its non-Large Corporate status:

The company confirmed that its outstanding borrowing of ₹0.43 crore as of March 31, 2026, falls significantly below the threshold criteria established under the SEBI circulars for Large Corporate identification.

Corporate Structure and Operations

Jeena Sikho Lifecare Limited operates over 120 Ayurveda clinics and hospitals, positioning itself in the healthcare sector with a focus on traditional medicine. The company maintains its registered office at SCO-11, Kalgidhar Enclave, Baltana, Zirakpur, Punjab-140604, while its corporate office is located at B-26, Opp. Metro Pillar No. 223, Rohtak Road, New Multan Nagar, Delhi - 110056.

Management Authorization

The disclosure was authorized by Manish Grover, Managing Director (DIN: 07557886), and signed digitally on April 16, 2026. The submission included signatures from key executives including Smita Chaturvedi, Company Secretary and Compliance Officer, and Nanak Chand, Chief Financial Officer, demonstrating proper corporate governance protocols.

Regulatory Implications

By confirming its non-Large Corporate status, Jeena Sikho Lifecare Limited clarifies that it is not subject to the enhanced regulatory requirements and borrowing frameworks applicable to larger entities. This classification affects the company's debt issuance procedures and compliance obligations under SEBI regulations, providing clarity to investors and regulatory authorities regarding its operational framework for the financial year 2026.

Jeena Sikho Lifecare Limited has received National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation for its Noida hospital facility. The company announced this development to stock exchanges on April 15, 2026, under Regulation 30 of SEBI listing requirements.

Accreditation Details

The NABH certification covers specific services and operational parameters at the company's Noida facility:

Significance of NABH Accreditation

The receipt of NABH accreditation represents adherence to nationally recognized standards across multiple operational areas. The certification validates the hospital's commitment to quality healthcare delivery, patient safety protocols, and operational excellence. NABH accreditation is considered a benchmark for healthcare institutions in India, ensuring compliance with established quality parameters.

Business Impact

Jeena Sikho Lifecare clarified that this accreditation occurred in the ordinary course of business operations. The company specifically noted that this development does not constitute business expansion, capacity enhancement, or acquisition activities. The accreditation applies to the existing Panchakarma services at the Noida facility.

Company Operations

Jeena Sikho Lifecare operates over 120 Ayurveda clinics and hospitals across its network. The company's registered office is located in Zirakpur, Punjab, while its corporate office operates from New Delhi. The Noida facility represents part of the company's existing healthcare infrastructure focused on traditional Ayurvedic treatments and wellness services.

The accreditation information has been made available on the company's website at www.jeenasikho.com , providing stakeholders with access to certification details and validity periods.